Bioseeker, Jan 2009 ... Lung Cancer Vaccine II-31 FASgen Announces Research Results of FAS093 II-31 The Cuban Regulatory Agency Registers a New Therapeutic Lung Cancer Vaccine II-31 ...
Business Insights, Aug 2005
Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. However, despite years. ...
Datamonitor, Jan 2002 ... to Active Immunotherapy: General Considerations 3.2 Active Immunotherapy Protocols in Preclinical Development 3.3 Therapeutic Cancer Vaccines in Preclinical ...
Datamonitor, June 2001 ...Vaccine Targets West Nile Virus Clostridium difficile Vaccines for Protection Against BioWarfare Therapeutic Disease Targets ...
Datamonitor, March 2007, Pages: 374
... on the progression of HBV disease, the increasing significance of HIV comorbidity and the prospective for prophylactic and therapeutic vaccine development for ...
Global Industry Analysts, Inc., April 2009, Pages: 739
... II-126 Ranbaxy Obtains Approval for RAN? Cefprozil Formulations in Canada II-126 Roche Partners with Transgene to Focus on Therapeutic Vaccine Program II-127 ...
John Wiley and Sons Ltd, July 2007, Pages: 528
... early to mid stage development, the entry of the therapies with novel mechanisms of actions, such as the angiogenesis inhibitors, therapeutic vaccines and gene ...
Datamonitor, April 2008, Pages: 187
... leukemia. Other notable candidates include the anti-idiotype therapeutic vaccines and Biogen Idecs anti-CD23 MAb, lumiliximab. Over ...
Datamonitor, Dec 2008, Pages: 267
... 2 Clinical Study II-64 Cytogen Receives FDA Clearance for CYT-500 IND Application II-64 US Researchers Unveils New Therapeutic Cancer Vaccine For Metastatic ...
Drug and Market Development Publishing, Dec 2005, Pages: 75
... Cytotoxic therapies account for 25% of the pipeline, while therapeutic vaccines account for 13%, and endocrine therapies account for just 6% of the pipeline. ...
Datamonitor, Oct 2003 ... strategies of cancer immunotherapy aim at exploiting the therapeutic potential of tumor-specific antibodies and cellular immune effector mechanisms (vaccines). ...